bretylium tosylate has been researched along with Myocardial Infarction in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (85.71) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Torresani, J | 1 |
| Sullivan, HE; Wehner, RJ | 1 |
| Holland, K; Lucchesi, BR; Patterson, E | 1 |
| Bacaner, MB; Hoey, MF; Macres, MG | 1 |
| Gibson, JK; Lucchesi, BR; Patterson, E | 1 |
| Gendenshteĭn, EI; Sernov, LN | 1 |
| Dorian, P | 1 |
| Binnion, PF; Das Gupta, R | 1 |
| Bigger, JT; Heissenbuttel, RH | 1 |
| Fallen, EL; Fraser, G; Holder, DA; Sniderman, AD | 1 |
| Corday, E; Drury, JK; Fishbein, MC; Hatori, N; Roberts, RL; Ryden, L; Satomura, K; Stiehm, ER; Tadokoro, H | 1 |
| Doherty, JE | 1 |
| Dłuzniewski, M | 1 |
| Anderson, JL | 1 |
5 review(s) available for bretylium tosylate and Myocardial Infarction
| Article | Year |
|---|---|
Prophylactic antiarrhythmic drug therapy in acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atropine; Bretylium Tosylate; Humans; Lidocaine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine | 1975 |
Bretylium tosylate: a newly available antiarrhythmic drug for ventricular arrhythmias.
Topics: Action Potentials; Adrenergic Fibers; Animals; Arrhythmias, Cardiac; Bretylium Compounds; Bretylium Tosylate; Drug Evaluation; Drug Interactions; Drug Resistance; Heart Conduction System; Humans; Infusions, Parenteral; Injections, Intramuscular; Injections, Intravenous; Myocardial Contraction; Myocardial Infarction; Pharmaceutical Vehicles; Purkinje Fibers; Quinidine; Sympathetic Nervous System; Tachycardia; Ventricular Fibrillation | 1979 |
Clinical use of digitalis glycosides. An update.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Age Factors; Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac; Biological Availability; Bretylium Tosylate; Deslanoside; Digitalis Glycosides; Digitoxin; Digoxin; Dose-Response Relationship, Drug; Drug Interactions; Heart Failure; Humans; Injections, Intramuscular; Injections, Intravenous; Intestinal Absorption; Kidney Failure, Chronic; Lidocaine; Metabolic Clearance Rate; Myocardial Infarction; Obesity; Phenytoin; Potassium; Pulmonary Heart Disease; Thyroid Diseases | 1985 |
[Bretylium tosylate in the treatment and prevention of ventricular arrhythmia: a new look at an old drug].
Topics: Bretylium Compounds; Bretylium Tosylate; Heart Ventricles; Hemodynamics; Humans; Myocardial Infarction; Ventricular Fibrillation | 1988 |
Bretylium tosylate: profile of the only available class III antiarrhythmic agent.
Topics: Administration, Oral; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Bretylium Tosylate; Chemical Phenomena; Chemistry; Coronary Disease; Dogs; Drug Implants; Electrophysiology; Heart Arrest; Hemodynamics; Humans; Injections, Intramuscular; Injections, Intravenous; Kinetics; Myocardial Infarction; Postoperative Complications; Tachycardia | 1985 |
9 other study(ies) available for bretylium tosylate and Myocardial Infarction
| Article | Year |
|---|---|
Bretylium tosylate in patients with acute myocardial infarction.
Topics: Animals; Arrhythmias, Cardiac; Bretylium Compounds; Bretylium Tosylate; Hemodynamics; Humans; Hypotension; Myocardial Contraction; Myocardial Infarction; Ventricular Fibrillation | 1984 |
Life threatening ventricular dysrhythmias: intervention with bretylium tosylate.
Topics: Arrhythmias, Cardiac; Bretylium Compounds; Bretylium Tosylate; Heart Ventricles; Hemodynamics; Humans; Myocardial Contraction; Myocardial Infarction; Stimulation, Chemical | 1983 |
Prevention of ventricular fibrillation by bretylium in a conscious canine model of sudden coronary death.
Topics: Animals; Bretylium Compounds; Bretylium Tosylate; Cardiac Pacing, Artificial; Consciousness; Death, Sudden; Dogs; Electrocardiography; Electrodes, Implanted; Heart Conduction System; Male; Myocardial Infarction; Risk; Ventricular Fibrillation | 1983 |
Suppression of ventricular fibrillation and positive inotropic action of bethanidine sulfate, a chemical analog of bretylium tosylate that is well absorbed orally.
Topics: Administration, Oral; Animals; Bethanidine; Blood Pressure; Bretylium Tosylate; Cardiac Output; Coronary Circulation; Dogs; Guanidines; Myocardial Contraction; Myocardial Infarction; Stimulation, Chemical; Structure-Activity Relationship; Ventricular Fibrillation | 1982 |
Postmyocardial infarction re-entrant ventricular arrhythmias in conscious dogs: suppression by bretylium tosylate.
Topics: Animals; Bretylium Compounds; Bretylium Tosylate; Catecholamines; Dogs; Heart Conduction System; Male; Myocardial Infarction; Refractory Period, Electrophysiological; Ventricular Fibrillation | 1981 |
[Correction of hypersensitivity to strophanthin in experimental myocardial infarction by pharmacologic effects on extracardiac innervation].
Topics: Animals; Atropine; Bretylium Tosylate; Cats; Drug Therapy, Combination; Drug Tolerance; Ephedrine; Female; Hexamethonium Compounds; Male; Myocardial Infarction; Neostigmine; Propranolol; Strophanthins; Sympatholytics | 1981 |
[Etiologies of electric storm].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Bretylium Tosylate; Electric Countershock; Female; Hemodynamics; Humans; Lidocaine; Male; Middle Aged; Myocardial Infarction; Recurrence; Risk Factors; Tachycardia, Ventricular; Ventricular Fibrillation | 1997 |
Experience with bretylium tosylate by a hospital cardiac arrest team.
Topics: Bretylium Compounds; Bretylium Tosylate; Emergency Service, Hospital; Evaluation Studies as Topic; Heart Arrest; Humans; Myocardial Infarction; Resuscitation; Ventricular Fibrillation | 1977 |
Differences in infarct size with lidocaine as compared with bretylium tosylate in acute myocardial ischemia and reperfusion in pigs.
Topics: Animals; Arterial Occlusive Diseases; Bretylium Tosylate; Coronary Circulation; Coronary Disease; Granulocytes; In Vitro Techniques; Leukocyte Adherence Inhibition Test; Lidocaine; Luminescent Measurements; Myocardial Infarction; Myocardial Reperfusion Injury; Necrosis; Oxygen Consumption; Superoxides; Swine | 1991 |